152 related articles for article (PubMed ID: 23142468)
1. Equine cytochrome P450 2B6--genomic identification, expression and functional characterization with ketamine.
Peters LM; Demmel S; Pusch G; Buters JT; Thormann W; Zielinski J; Leeb T; Mevissen M; Schmitz A
Toxicol Appl Pharmacol; 2013 Jan; 266(1):101-8. PubMed ID: 23142468
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs.
Capponi L; Schmitz A; Thormann W; Theurillat R; Mevissen M
Am J Vet Res; 2009 Jun; 70(6):777-86. PubMed ID: 19496669
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T
Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of 26 CYP2B6 allelic variants (CYP2B6.2-CYP2B6.28, except CYP2B6.22).
Watanabe T; Sakuyama K; Sasaki T; Ishii Y; Ishikawa M; Hirasawa N; Hiratsuka M
Pharmacogenet Genomics; 2010 Jul; 20(7):459-62. PubMed ID: 20517174
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2B6: function, genetics, and clinical relevance.
Turpeinen M; Zanger UM
Drug Metabol Drug Interact; 2012; 27(4):185-97. PubMed ID: 23152403
[TBL] [Abstract][Full Text] [Related]
7. Role of CYP2B6 in stereoselective human methadone metabolism.
Totah RA; Sheffels P; Roberts T; Whittington D; Thummel K; Kharasch ED
Anesthesiology; 2008 Mar; 108(3):363-74. PubMed ID: 18292673
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism of testosterone in the horse liver and involvement of equine CYPs 3A89, 3A94 and 3A95.
Schmitz A; Zielinski J; Dick B; Mevissen M
J Vet Pharmacol Ther; 2014 Aug; 37(4):338-47. PubMed ID: 24479850
[TBL] [Abstract][Full Text] [Related]
9. The CYP2B6*6 allele significantly alters the N-demethylation of ketamine enantiomers in vitro.
Li Y; Coller JK; Hutchinson MR; Klein K; Zanger UM; Stanley NJ; Abell AD; Somogyi AA
Drug Metab Dispos; 2013 Jun; 41(6):1264-72. PubMed ID: 23550066
[TBL] [Abstract][Full Text] [Related]
10. Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis.
Sandbaumhüter FA; Vimercati S; Thormann W; Mevissen M
Toxicol In Vitro; 2018 Aug; 50():242-248. PubMed ID: 29614330
[TBL] [Abstract][Full Text] [Related]
11. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
[TBL] [Abstract][Full Text] [Related]
12. Stable expression of human cytochrome CYP2B6 and CYP1A1 in Chinese hamster CHL cells: their use in micronucleus assays.
Wu J; Dong H; Cai Z; Yu Y
Chin Med Sci J; 1997 Sep; 12(3):148-55. PubMed ID: 11360624
[TBL] [Abstract][Full Text] [Related]
13. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.
Miksys S; Tyndale RF
Drug Metab Rev; 2004 May; 36(2):313-33. PubMed ID: 15237857
[TBL] [Abstract][Full Text] [Related]
14. [Cyclophosphamide and CYP2B6].
Torimoto Y; Kohgo Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1090-3. PubMed ID: 18633247
[TBL] [Abstract][Full Text] [Related]
15. Human CYP2B6: expression, inducibility and catalytic activities.
Gervot L; Rochat B; Gautier JC; Bohnenstengel F; Kroemer H; de Berardinis V; Martin H; Beaune P; de Waziers I
Pharmacogenetics; 1999 Jun; 9(3):295-306. PubMed ID: 10471061
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.
Mo SL; Liu YH; Duan W; Wei MQ; Kanwar JR; Zhou SF
Curr Drug Metab; 2009 Sep; 10(7):730-53. PubMed ID: 19702527
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes.
Bae SK; Cao S; Seo KA; Kim H; Kim MJ; Shon JH; Liu KH; Zhou HH; Shin JG
Drug Metab Dispos; 2008 Aug; 36(8):1679-88. PubMed ID: 18474675
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.
Zanger UM; Klein K; Saussele T; Blievernicht J; Hofmann MH; Schwab M
Pharmacogenomics; 2007 Jul; 8(7):743-59. PubMed ID: 17638512
[TBL] [Abstract][Full Text] [Related]
19. Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro.
Portmann S; Kwan HY; Theurillat R; Schmitz A; Mevissen M; Thormann W
J Chromatogr A; 2010 Dec; 1217(51):7942-8. PubMed ID: 20609441
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of CYP2B6 cDNA in cynomolgus macaques (Macaca fascicularis).
Uno Y; Matsuno K; Nakamura C; Utoh M; Yamazaki H
J Vet Med Sci; 2009 Dec; 71(12):1653-6. PubMed ID: 20046035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]